Search Results

There are 7333 results for: content related to: Belimumab: targeted therapy for lupus

  1. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  2. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  3. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  4. Biomarkers for systemic lupus erythematosus

    International Journal of Rheumatic Diseases

    Volume 15, Issue 5, October 2012, Pages: 433–444, Ronald Herbst, Zheng Liu, Bahija Jallal and Yihong Yao

    Version of Record online : 8 JUL 2012, DOI: 10.1111/j.1756-185X.2012.01764.x

  5. You have free access to this content
    A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

    Arthritis Care & Research

    Volume 61, Issue 9, 15 September 2009, Pages: 1168–1178, Daniel J. Wallace, William Stohl, Richard A. Furie, Jeffrey R. Lisse, James D. McKay, Joan T. Merrill, Michelle A. Petri, Ellen M. Ginzler, W. Winn Chatham, W. Joseph McCune, Vivian Fernandez, Marc R. Chevrier, Z. John Zhong and William W. Freimuth

    Version of Record online : 27 AUG 2009, DOI: 10.1002/art.24699

  6. You have free access to this content
    Poster Presentation Abstracts

    International Journal of Rheumatic Diseases

    Volume 19, Issue S2, September 2016, Pages: 21–293,

    Version of Record online : 19 SEP 2016, DOI: 10.1111/1756-185X.12962

  7. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations

    International Journal of Rheumatic Diseases

    Volume 18, Issue 2, February 2015, Pages: 117–128, Young Bin Joo and Sang Cheol Bae

    Version of Record online : 19 DEC 2014, DOI: 10.1111/1756-185X.12462

  8. You have free access to this content
    Novel evidence-based systemic lupus erythematosus responder index

    Arthritis Care & Research

    Volume 61, Issue 9, 15 September 2009, Pages: 1143–1151, Richard A. Furie, Michelle A. Petri, Daniel J. Wallace, Ellen M. Ginzler, Joan T. Merrill, William Stohl, W. Winn Chatham, Vibeke Strand, Arthur Weinstein, Marc R. Chevrier, Z. John Zhong and William W. Freimuth

    Version of Record online : 27 AUG 2009, DOI: 10.1002/art.24698

  9. Current role of rituximab in systemic lupus erythematosus

    International Journal of Rheumatic Diseases

    Volume 18, Issue 2, February 2015, Pages: 154–163, Chi Chiu Mok

    Version of Record online : 19 DEC 2014, DOI: 10.1111/1756-185X.12463

  10. Real-Time PCR of cytomegalovirus and Epstein–Barr virus in adult Egyptian patients with systemic lupus erythematosus

    International Journal of Rheumatic Diseases

    Volume 18, Issue 4, May 2015, Pages: 452–458, Aly E. Mohamed, Amany M. Hasen, Ghada F. A. Mohammed and Nermin N. Elmaraghy

    Version of Record online : 16 DEC 2013, DOI: 10.1111/1756-185X.12261

  11. You have free access to this content
    Vitamin D and systemic lupus erythematosus: continued evolution

    International Journal of Rheumatic Diseases

    Volume 18, Issue 2, February 2015, Pages: 242–249, Kristy S. Yap and Eric F. Morand

    Version of Record online : 19 DEC 2014, DOI: 10.1111/1756-185X.12489

  12. You have free access to this content
    ABSTRACTS – Online Panel Discussion (i-Pos)

    International Journal of Rheumatic Diseases

    Volume 11, Issue s1, September 2008, Pages: A84–A514,

    Version of Record online : 31 AUG 2008, DOI: 10.1111/j.1479-8077.2008.00373.x

  13. Peripheral CD24hiCD27+CD19+B cells subset as a potential biomarker in naïve systemic lupus erythematosus

    International Journal of Rheumatic Diseases

    Volume 16, Issue 6, December 2013, Pages: 698–708, Lin Jin, Chen Weiqian and Yue Lihuan

    Version of Record online : 28 NOV 2013, DOI: 10.1111/1756-185X.12229

  14. You have free access to this content
    Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus

    Arthritis & Rheumatism

    Volume 58, Issue 8, August 2008, Pages: 2453–2459, Michelle Petri, William Stohl, Winn Chatham, W. Joseph McCune, Marc Chevrier, Jeff Ryel, Virginia Recta, John Zhong and William Freimuth

    Version of Record online : 30 JUL 2008, DOI: 10.1002/art.23678

  15. You have free access to this content
    A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

    Arthritis & Rheumatism

    Volume 63, Issue 12, December 2011, Pages: 3918–3930, Richard Furie, Michelle Petri, Omid Zamani, Ricard Cervera, Daniel J. Wallace, Dana Tegzová, Jorge Sanchez-Guerrero, Andreas Schwarting, Joan T. Merrill, W. Winn Chatham, William Stohl, Ellen M. Ginzler, Douglas R. Hough, Z. John Zhong, William Freimuth, Ronald F. van Vollenhoven and BLISS-76 Study Group

    Version of Record online : 29 NOV 2011, DOI: 10.1002/art.30613

  16. You have free access to this content
    Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus

    Arthritis & Rheumatism

    Volume 64, Issue 7, July 2012, Pages: 2328–2337, William Stohl, Falk Hiepe, Kevin M. Latinis, Mathew Thomas, Morton A. Scheinberg, Ann Clarke, Cynthia Aranow, Frank R. Wellborne, Carlos Abud-Mendoza, Douglas R. Hough, Lilia Pineda, Thi-Sau Migone, Z. John Zhong, William W. Freimuth, W. Winn Chatham and on behalf of the BLISS-52 and BLISS-76 Study Groups

    Version of Record online : 26 JUN 2012, DOI: 10.1002/art.34400

  17. You have free access to this content
    Baseline Predictors of Systemic Lupus Erythematosus Flares: Data From the Combined Placebo Groups in the Phase III Belimumab Trials

    Arthritis & Rheumatism

    Volume 65, Issue 8, August 2013, Pages: 2143–2153, Michelle A. Petri, Ronald F. van Vollenhoven, Jill Buyon, Roger A. Levy, Sandra V. Navarra, Ricard Cervera, Z. John Zhong, William W. Freimuth and on behalf of the BLISS-52 and BLISS-76 Study Groups

    Version of Record online : 26 JUL 2013, DOI: 10.1002/art.37995

  18. Circulating microparticles in neuropsychiatric systemic lupus erythematosus

    International Journal of Rheumatic Diseases

    Volume 16, Issue 1, February 2013, Pages: 72–80, Kendall P. Crookston, Wilmer L. Sibbitt Jr., Wayne. L. Chandler, Clifford R. Qualls and Carlos A. Roldan

    Version of Record online : 18 JAN 2013, DOI: 10.1111/1756-185x.12026

  19. You have free access to this content
    Arthritis & Rheumatism, 2001 Annual Scientific Meeting Abstracts, November 10–15, 2001, San Francisco, CA

    Arthritis & Rheumatism

    Volume 44, Issue S9, September 2001, Pages: 277–390,

    Version of Record online : 22 FEB 2002, DOI: 10.1002/1529-0131(200109)44:9+<::AID-ART427>3.0.CO;2-4

  20. Belimumab therapy for systemic lupus erythematosus and potential treatment of rheumatoid arthritis

    Drug Development Research

    Volume 72, Issue 7, November 2011, Pages: 623–633, Changhai Ding, Ran Li, Jianhua Xu, Flavia Cicuttini and Graeme Jones

    Version of Record online : 23 NOV 2011, DOI: 10.1002/ddr.20472